APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETS 50 MG
DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE) : 50 MG · DIN 02467119 · APOTEX INC
Health Canada status: DORMANT
What is APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETS?
APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETS 50 MG contains DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE) : 50 MG. It is listed in the Health Canada Drug Product Database under DIN 02467119, held by APOTEX INC, supplied as TABLET (EXTENDED-RELEASE) for ORAL administration. Health Canada currently lists it as dormant, status dated 19-Apr-2025. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02467119 |
|---|---|
| Brand name | APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETS |
| Generic / active ingredient | DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE) : 50 MG |
| Manufacturer | APOTEX INC |
| Strength | 50 MG |
| Dosage form | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | N06AX23 DESVENLAFAXINE |
| AHFS class | 28:16.04.16 |
| Biosimilar | No |
| Health Canada status | DORMANT |
| Status date | 19-Apr-2025 |
| Original market date | 2022-04-26 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code N06AX23 DESVENLAFAXINE. 20 of 28 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| AG-DESVENLAFAXINE | 100 MG | TABLET (EXTENDED-RELEASE) | ANGITA PHARMA INC. | MARKETED | DIN 02525623 |
| AG-DESVENLAFAXINE | 50 MG | TABLET (EXTENDED-RELEASE) | ANGITA PHARMA INC. | MARKETED | DIN 02525615 |
| APO-DESVENLAFAXINE | 100 MG | TABLET (EXTENDED-RELEASE) | APOTEX INC | MARKETED | DIN 02466996 |
| APO-DESVENLAFAXINE | 50 MG | TABLET (EXTENDED-RELEASE) | APOTEX INC | MARKETED | DIN 02466988 |
| DESVENLAFAXINE | 100 MG | TABLET (EXTENDED-RELEASE) | SANIS HEALTH INC | MARKETED | DIN 02535114 |
| DESVENLAFAXINE | 100 MG | TABLET (EXTENDED-RELEASE) | SIVEM PHARMACEUTICALS ULC | MARKETED | DIN 02554976 |
| DESVENLAFAXINE | 100 MG | TABLET (EXTENDED-RELEASE) | PRO DOC LIMITEE | MARKETED | DIN 02543680 |
| DESVENLAFAXINE | 50 MG | TABLET (EXTENDED-RELEASE) | SANIS HEALTH INC | MARKETED | DIN 02535106 |
| DESVENLAFAXINE | 50 MG | TABLET (EXTENDED-RELEASE) | PRO DOC LIMITEE | MARKETED | DIN 02543672 |
| DESVENLAFAXINE | 50 MG | TABLET (EXTENDED-RELEASE) | SIVEM PHARMACEUTICALS ULC | MARKETED | DIN 02554968 |
Who else supplies DESVENLAFAXINE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. DESVENLAFAXINE appears in 244 registered pack listings across 6 markets, published on 5 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Request a quote for APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETS
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.